Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Metanephric organ culture.

Maser RL, Magenheimer BS, Calvet JP.

Methods Cell Biol. 2019;153:169-183. doi: 10.1016/bs.mcb.2019.04.018. Epub 2019 Jun 13.

PMID:
31395378
2.

A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.

Parnell SC, Magenheimer BS, Maser RL, Pavlov TS, Havens MA, Hastings ML, Jackson SF, Ward CJ, Peterson KR, Staruschenko A, Calvet JP.

Hum Mol Genet. 2018 Oct 1;27(19):3313-3324. doi: 10.1093/hmg/ddy223.

3.

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.

Idowu J, Home T, Patel N, Magenheimer B, Tran PV, Maser RL, Ward CJ, Calvet JP, Wallace DP, Sharma M.

Sci Rep. 2018 Feb 20;8(1):3340. doi: 10.1038/s41598-018-21132-3.

4.

Primary Cilia in Cystic Kidney Disease.

Avasthi P, Maser RL, Tran PV.

Results Probl Cell Differ. 2017;60:281-321. doi: 10.1007/978-3-319-51436-9_11. Review.

PMID:
28409350
5.

Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease.

Kurbegovic A, Kim H, Xu H, Yu S, Cruanès J, Maser RL, Boletta A, Trudel M, Qian F.

Mol Cell Biol. 2014 Sep;34(17):3341-53. doi: 10.1128/MCB.00687-14. Epub 2014 Jun 23.

6.

Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease.

Galarreta CI, Grantham JJ, Forbes MS, Maser RL, Wallace DP, Chevalier RL.

Am J Pathol. 2014 Jul;184(7):1957-66. doi: 10.1016/j.ajpath.2014.03.007. Epub 2014 May 9.

7.

Overexpression of the polycystin-1 C-tail enhances sensitivity of M-1 cells to ouabain.

Jansson K, Magenheimer BS, Maser RL, Calvet JP, Blanco G.

J Membr Biol. 2013 Jul;246(7):581-90. doi: 10.1007/s00232-013-9573-4. Epub 2013 Jun 20.

8.

Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Nims NM, Vassmer D, Maser RL.

Biochemistry. 2011 Jan 25;50(3):349-55. Epub 2010 Dec 29.

9.

MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Islam MR, Jimenez T, Pelham C, Rodova M, Puri S, Magenheimer BS, Maser RL, Widmann C, Calvet JP.

J Biol Chem. 2010 Dec 10;285(50):38818-31. doi: 10.1074/jbc.M110.145284. Epub 2010 Oct 5.

10.

Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.

Islam MR, Puri S, Rodova M, Magenheimer BS, Maser RL, Calvet JP.

Am J Physiol Renal Physiol. 2008 Dec;295(6):F1845-54. doi: 10.1152/ajprenal.90355.2008. Epub 2008 Oct 15.

11.

Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.

Alcalay NI, Sharma M, Vassmer D, Chapman B, Paul B, Zhou J, Brantley JG, Wallace DP, Maser RL, Vanden Heuvel GB.

Am J Physiol Renal Physiol. 2008 Dec;295(6):F1725-34. doi: 10.1152/ajprenal.90420.2008. Epub 2008 Oct 1.

12.

Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.

Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP.

J Am Soc Nephrol. 2006 Dec;17(12):3424-37. Epub 2006 Nov 15.

13.

Ets factors regulate the polycystic kidney disease-1 promoter.

Puri S, Rodova M, Islam MR, Magenheimer BS, Maser RL, Calvet JP.

Biochem Biophys Res Commun. 2006 Apr 21;342(4):1005-13. Epub 2006 Feb 20.

PMID:
16510125
14.

Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice.

Sharma M, Brantley JG, Alcalay NI, Zhou J, Heystek E, Maser RL, Vanden Heuvel GB.

Kidney Int. 2005 Feb;67(2):432-42.

15.

Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway.

Puri S, Magenheimer BS, Maser RL, Ryan EM, Zien CA, Walker DD, Wallace DP, Hempson SJ, Calvet JP.

J Biol Chem. 2004 Dec 31;279(53):55455-64. Epub 2004 Oct 5.

17.

Transient transfection assays for analysis of signal transduction in renal cells.

Maser RL, Magenheimer BS, Zien CA, Calvet JP.

Methods Mol Med. 2003;86:205-17. No abstract available.

PMID:
12886771
18.

Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.

Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD, Grantham JJ.

Kidney Int. 2003 Feb;63(2):427-37.

19.

The polycystic kidney disease-1 promoter is a target of the beta-catenin/T-cell factor pathway.

Rodova M, Islam MR, Maser RL, Calvet JP.

J Biol Chem. 2002 Aug 16;277(33):29577-83. Epub 2002 Jun 4.

20.

Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease.

Maser RL, Vassmer D, Magenheimer BS, Calvet JP.

J Am Soc Nephrol. 2002 Apr;13(4):991-9.

21.

Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins.

Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frischauf AM, Calvet JP.

J Biol Chem. 2002 May 31;277(22):19566-72. Epub 2002 Mar 23.

22.

Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.

Sutters M, Yamaguchi T, Maser RL, Magenheimer BS, St John PL, Abrahamson DR, Grantham JJ, Calvet JP.

Kidney Int. 2001 Aug;60(2):484-94.

23.

Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain.

Parnell SC, Magenheimer BS, Maser RL, Calvet JP.

Biochem Biophys Res Commun. 1999 Jun 16;259(3):539-43.

PMID:
10364454
24.
25.

The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.

Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T, Calvet JP.

Biochem Biophys Res Commun. 1998 Oct 20;251(2):625-31.

PMID:
9792824
28.

Growth characteristics of cells cultured from two murine models of polycystic kidney disease.

Rankin CA, Ziemer DM, Maser RL, Foo I, Calvet JP.

In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):100-6.

PMID:
8907123
30.
31.
32.

U6 small nuclear RNA is transcribed by RNA polymerase III.

Kunkel GR, Maser RL, Calvet JP, Pederson T.

Proc Natl Acad Sci U S A. 1986 Nov;83(22):8575-9.

33.

Physical map of a plasmid from Caedibacter taeniospiralis 51.

Quackenbush RL, Dilts JA, Maser RL.

J Bacteriol. 1982 Nov;152(2):939-42.

Supplemental Content

Loading ...
Support Center